Patents Assigned to The Trustees of Columbia University in the City of New York
  • Patent number: 11028098
    Abstract: The present invention provide a compound having the structure: (structurally represented) wherein R1, R2, R3, R4, and R5 are each independently H, halogen, CF3 or C1-C4 alkyl; R6 is H, OH, or halogen; B is a substituted or unsubstituted heterobicycle, pyridazine, pyrazole, pyrazine, thiadiazole, or triazole, wherein the heterocycle is other than chloro substituted indole; and the pyrazole, when substituted, is substituted with other than trifluoromethyl, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: June 8, 2021
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Konstantin Petrukhin, Christopher Cioffi, Graham Johnson, Nicoleta Dobri, Emily Freeman, Ping Chen, Michael Conlon, Lei Zhu
  • Patent number: 11026996
    Abstract: This invention provides a fusion protein, the sequence of which, commencing at the N-terminus of the fusion protein, is identical to the sequence of amino acids in: (a) an extracellular domain of a human Notch1 receptor protein, followed by (b) an Fc portion of an antibody, wherein the extracellular domain of the human Notch1 receptor protein (i) commences with the amino acid present at the N-terminus of EGF-like repeat 10 and (ii) extends to and includes the C-terminal amino acid of EGF-like repeat 18 or 20. Also provided is a composition comprising the any of the fusion proteins of this invention and a pharmaceutically acceptable carrier, a method of treating a subject suffering from age-related macular degeneration (AMD), diabetic retinopathy, or cancer which comprises administering to the subject any of the compositions of this invention in an amount effective to treat the subject's cancer.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: June 8, 2021
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Jan Kitajewski, Reyhaan Ali Chaudhri
  • Patent number: 11031665
    Abstract: A circuit comprising a differential transmission line and eight switches provides non-reciprocal signal flow. In some embodiments, the circuit can be driven by four local oscillator signals. The circuit can be used to form a gyrator. The circuit can be used to form a circulator. The circuit can be used to form three-port circulator than can provide direction signal flow between a transmitter and an antenna and from the antenna to a receiver. The three-port circulator can be used to implement a full duplex transceiver that uses a single antenna for transmitting and receiving.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: June 8, 2021
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Tolga Dinc, Harish Krishnaswamy
  • Publication number: 20210165206
    Abstract: A switchable light transmission module is disclosed that includes a substrate having a first surface defining at least part of an enclosed volume, a porous layer disposed on the first surface and in fluid communication with the enclosed volume, and a reservoir in fluid communication with the enclosed volume. The reservoir is configured to supply a fluid to the sealed volume such that the fluid contacts the porous layer. The fluid has a refractive index that is close to the refractive index of the porous layer, has a high wettability for the porous layer, and does not dissolve the porous layer. When in a dry state, voids in the porous layer are filled with air which has a much different refractive index than the porous layer itself, resulting in a surface that is reflective and not very transmissive.
    Type: Application
    Filed: December 10, 2018
    Publication date: June 3, 2021
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Jyotirmoy MANDAL, Yuan YANG, Nanfang YU
  • Patent number: 11020465
    Abstract: Disclosed herein is a different and novel approach to cancer vaccines using a subject's own dendritic cells (DCs) and macrophages (Mphs) in combination to present cancer antigens to the immune system. Further disclosed are methods of producing monocyte-derived autologous DCs and Mphs loaded ex vivo with particular whole irradiated cancer cells which generates optimally activated immunostimulatory antigen-presenting cells (APCs) as a superior method for stimulating robust and long-lasting immunity to a particular cancer in vivo as compared with more traditional vaccination methods. Compositions, methods of use and methods for preparation of these DCs and Mphs with cancer cells are also disclosed herein.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: June 1, 2021
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Gavreel Kalantarov, Ilya Trakht
  • Patent number: 11020617
    Abstract: Techniques for modulating peripheral nerves using focused ultrasound (FUS) are provided. Methods include locating a peripheral nerve in a subject using an imaging probe, providing a FUS having one or more ultrasound parameters to a location on the peripheral nerve, and modulating the peripheral nerve. The methods can further include eliciting and measuring a physiological response from the FUS modulation, generating tissue deformation in the vicinity of the FUS modulation, and imaging the nerve and the tissue deformation simultaneously with FUS modulation. Systems for use in the modulation of peripheral nerves are also provided.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: June 1, 2021
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Elisa E. Konofagou, Matthew Downs, Stephen Lee, Min Gon Kim, Hermes Arytto Salles Kamimura
  • Patent number: 11013938
    Abstract: Techniques for modulating peripheral nerves using focused ultrasound (FUS) are provided. Methods include locating a peripheral nerve in a subject using an imaging probe, providing a FUS having one or more ultrasound parameters to a location on the peripheral nerve, and modulating the peripheral nerve. The methods can further include eliciting and measuring a physiological response from the FUS modulation, generating tissue deformation in the vicinity of the FUS modulation, and imaging the nerve and the tissue deformation simultaneously with FUS modulation. Systems for use in the modulation of peripheral nerves are also provided.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: May 25, 2021
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Elisa E. Konofagou, Matthew Downs
  • Patent number: 11013934
    Abstract: Certain exemplary embodiments of the present disclosure can provide an apparatus and method for generating at least one radiation. The exemplary apparatus and/or method can selectively kill and/or affect at least one bacteria. For example, a radiation source first arrangement can be provided which is configured to generate at least one radiation having one or more wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm, and at least one second arrangement can be provided which is configured to prevent the at least one radiation from having any wavelength that is outside of the range.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: May 25, 2021
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Gerhard Randers-Pehrson, David Jonathan Brenner, Alan Bigelow
  • Patent number: 11007291
    Abstract: Certain exemplary embodiments of the present disclosure can provide an apparatus and method for generating at least one radiation can be provided. The exemplary apparatus and/or method can selectively kill and/or affect at least one virus. For example, a radiation source first arrangement can be provided which is configured to generate at least one radiation having one or more wavelengths provided in a range of about 200 nanometers (nm) to about 230 nm, and at least one second arrangement can be provided which is configured to prevent the at least one radiation from having any wavelength that is outside of the range can be provided or which can be substantially harmful to cells of the body.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: May 18, 2021
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Gerhard Randers-Pehrson, David Jonathan Brenner, Alan Bigelow
  • Patent number: 11008341
    Abstract: The present application discloses compounds which are activators of autophagic flux and pharmaceutical compositions comprising said activators. It further discloses use of said compounds and pharmaceutical compositions in the treatment of neurodegenerative diseases, particularly proteinopathies and tauopathies such as Alzheimer's disease. It further discloses methods of enhancing autophagic flux.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: May 18, 2021
    Assignees: The Trustees of Columbia University in the City of New York, NY State Psychiatric Institute
    Inventors: Kirsten Alison Rinderspacher, Wai Yu, Karen Duff, Donald Landry, Shi-Xian Deng
  • Patent number: 11007380
    Abstract: Certain exemplary embodiments of the present disclosure can provide an apparatus and method for generating at least one radiation can be provided. The exemplary apparatus and for method can selectively kill and/or affect at least one bacteria. For example, a radiation source first arrangement can be provided which is configured to generate at least one radiation having one or More wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm, and at least one second arrangement can be provided which is configured to prevent the at least one radiation from having any wavelength that is outside of the range.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: May 18, 2021
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Gerhard Randers-Pehrson, David Jonathan Brenner, Alan Bigelow
  • Publication number: 20210139976
    Abstract: The invention provides various orthogonal nucleotide analogues and methods for using combinations of said various orthogonal nucleotide analogues for sequencing by synthesis.
    Type: Application
    Filed: March 14, 2019
    Publication date: May 13, 2021
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Jingyue Ju, Xiaoxu Li, Shiv Kumar, Xin Chen, James J. Russo, Minchen Chien, Steffen Jockusch, Chuanjuan Tao, Xuanting Wang, Sergey Kalachikov, Irina Morozova, Shundi Shi
  • Publication number: 20210143480
    Abstract: Disclosed is an electrolyte in communication with an anode and a cathode of a battery. The electrolyte includes a eutectic solvent including ?-caprolactam (CPL), acetamide, imidazole, urea, amide, o-toluic acid, benzoic acid, furoic acid, quaternary ammonium type salts, or combinations thereof in equimolar concentration; and a sulfide. The sulfide including an alkali sulfide, an alkali polysulfide, or combinations thereof. Also disclosed is a battery including an anode and a cathode and the aforementioned electrolyte.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 13, 2021
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Yuan YANG, Qian CHENG, Weiheng XU
  • Publication number: 20210140054
    Abstract: A system for producing hydrogen gas from biomass is disclosed that includes a first reaction chamber having one or more hydroxides, a Ni/ZrO2 catalyst, and a source of moistened seaweed biomass therein. A heat source is in communication with the first reaction chamber. One or more product streams exit the first reaction chamber including, hydrogen gas, a carbonate, or combinations thereof. A recycle stream provides recycled hydroxide to the first reaction chamber and the product stream is produced as a result of reaction of the seaweed biomass source with the one or more hydroxides in the presence of the Ni/ZrO2 catalyst.
    Type: Application
    Filed: January 22, 2021
    Publication date: May 13, 2021
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Ah-Hyung Alissa PARK, Woojae KIM
  • Patent number: 11000492
    Abstract: The present invention provides a method for treating or preventing gout in a subject afflicted therewith comprising administering a compound presented or an ester or salt thereof, so as to thereby treat or prevent the gout in the subject.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: May 11, 2021
    Assignee: The Trustees of Columbia University in the City of New York
    Inventor: Konstantin Petrukhin
  • Publication number: 20210134402
    Abstract: System and methods for predicting success rates of clinical trials are disclosed. The system can comprise one or more processors and one or more computer-readable non-transitory storage media coupled to the one or more of processors including instructions operable when executed by one or more of the processor. The system is configured to cause the system to construct a training set using a data source, a performance score and a robustness score of the training set based on selected features, a random forest model based on the calculated performance and robustness scores; and calculate a toxicity score of the pharmaceuticals by applying the random forest model to a genome which is affected by the pharmaceuticals. Methods for predicting success rates of clinical trials and pharmaceuticals are also provided.
    Type: Application
    Filed: October 30, 2020
    Publication date: May 6, 2021
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Nicholas TATONETTI, Yun HAO
  • Patent number: 10994157
    Abstract: The invention provides for methods for treating a hair loss disorder in a subject by administering a Janus Kinase/Signal Transducers and Activators of Transcription inhibitor.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: May 4, 2021
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Angela M. Christiano, Raphael Clynes
  • Patent number: 10994153
    Abstract: Certain exemplary embodiments of the present disclosure can provide an apparatus and method for generating at least one radiation can be provided. The exemplary apparatus and/or method can selectively kill and/or affect at least one bacteria. For example, a radiation source first arrangement can be provided which is configured to generate at least one radiation having one or more wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm, and at least one second arrangement can be provided which is configured to prevent the at least one radiation from having any wavelength that is outside of the range can be provided.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: May 4, 2021
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Gerhard Randers-Pehrson, David Jonathan Brenner, Alan Bigelow
  • Publication number: 20210123052
    Abstract: The present disclosure relates generally to oligonucleotide production. In particular it relates to in vivo single stranded DNA (ssDNA) production.
    Type: Application
    Filed: October 26, 2020
    Publication date: April 29, 2021
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Alejandro Chavez, Schuyler Melore
  • Patent number: 10980883
    Abstract: Various exemplary photoreactions can be provided, including reactions generally based on triplet-triplet annihilation upconversion. Representative photosensitizers include PdPc(OBu)8 and PtTPTNP. Representative annihilators include FDPP and TTBP. Such exemplary photoreactions, systems and methods may be used in a variety of applications, including various biological or physical applications. Exemplary methods can also be provided for making or using such systems, photoreactions, kits including such systems, or the like.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: April 20, 2021
    Assignees: The Trustees of Columbia University in the City of New York, President and Fellows of Harvard College
    Inventors: Luis M. Campos, Daniel N. Congreve, Andrew Brian Pun, Kealan Fallon, Emily Marie Churchill, Tomislav Rovis, Benjamin Ravetz